NK Cells Flashcards

1
Q

What are NK Cells?

A
Natural killer ( NK ) cells constitute the first line of
defence against cancer and form a subset of the innate lymphoid cell ( ILC ) family, ILC1 , with cytotoxic properties resembling CD8+ T cells - controlling viral, bacterial infection and tumor growth.

5-25% of lymphocytes in blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hvad genkender NK Celler? Og har de unik antigen specifikke receptorer?

A
- Nej.
In contrast to adaptive immune T cells, ILCs lack rearranged unique antigen-specific receptors and, instead, express germline-encoded receptors that recognize common ligands upregulated in cells under stress caused by infection, DNA damage, or malignant transformation, such as MHC class I chain-related gene A and B ( MICA/ B) and UL16-binding proteins ( ULBPs1- 6).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hvordan modbalancerer NK Celler deres aktiverende receptorer?

A

To counterbalance activating receptors, NK cells express killer inhibitory receptors ( KIR ), primarily directed against self MHC class I molecules to prevent autoreactivity. NK cells can also be shaped by the tumor microenvironment to express checkpoint inhibitors, such as programmed cell death protein-1 ( PD - 1), lymphocyte activating gene 3 ( LAG- 3), and T cell Ig mucin receptor 3 ( TIM- 3 ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hvad muliggør CD16 i NK Celler?

A

Mediate antibody dependent cell-mediated cytotoxicity ( ADCC ) via expression of CD16.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NK Cells stammer fra?

A

Hematopoietic Stemm Cells (HSC) –> Common Lymphoid Pregoenitor (CLP) –> Common Helper-ILC Precursor (CHILP) –> NK Cells (ILC-1)+ ILC-1, ILC-2, ILC-3.
- ILC-1,-2,-3 er non cytotoksiske og komplementerer T helper cells vha. pro-inflammatoriske cytokiner, som tilsammen aktiverer CTL’s (Cytotoxic T Lymphocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hvilke typer af NK celler findes der?

A

1) Cytotoxic NK Cells (CD56+, CD16++)
2) Cytokine producing NK Cells, IFN-g (CD56++, CD16low)

Det er selvfølgelig et spektruM!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hvilke funktioner har de foskellige NK Celler?

A

NK Cells: Genkende inficerede celler samt tumorer og dræbe disse vha. Granzym, perforiner og Interferon Gamma.
ILC-1: Understøtter T hjælper celler vha. cytokiner og igangsætter CTL (Cd8+ T celler) og T celle responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hvad er CD16?

A
  • Cluster of Differentiation 16 er en Fc receptor nødvendig for ADCC hos NK Cells. CD16 binder antistoffer (IgG i deres Fc del)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hvordan aktiveres NK Celler?

A
  • NK Celler reguleres via en balance af inhiberende og aktiverende signaler fra cellerne den interaggerer med. Denne balance afgør om en NK celle aktiveres eller ej.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hvilke aktiverende receptorer/ligander til NK Celler kender du?

A
  • aKIR (Binder MHC-I)
  • NKG2D (binder MICA/B)
  • CD16 (Binder FC delen af IgG antistoffer)
  • NCR (Natural Cytotoxicity Receptor)
  • 2B4 (med dens CD48 ligand)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hvilke inhiberende receptorer/ligander til NK Celler kender du?

A
  • MHC-I er en kritisk inhiberende ligand - modvirker reaktion mod “self”.
  • iKIR (Binder MHC-I, HLA molekyler)
  • NKG2A (Binder HLA-E)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Kan aktiverende signaler for NK celler selv signal transducere??

A

Nej, ofte har de korte cytoplasmiske haler uden signal transducerende egenskaber.
- De associerer generelt med adapter molekyler med ITAMS der, når de fosforyleres, aktiverer downstream signalering.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Kan aktiverende signaler for NK celler signal transducere?

A

Nej, ofte har de korte cytoplasmiske haler uden signal transducerende egenskaber.
- De associerer generelt med adapter molekyler gennem ladede aminosyrer som indeholder ITAMS der, når de fosforyleres, aktiverer downstream signalering. Der resulterer i cytokine eller lytiske granulae frigørelse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Kan inhiberende signaler for NK celler selv signal transucere?

A
  • Ja, det har ofte lange cytoplasmiske haler med ITIMs (immunoreceptor tyrosine-based inhibition motifs). Der når de aktiveres fosforyleres af Lck og Fyn. Herefter kan SHP-1,-2 og SHIP-1,-2 fosforyleres og aktiveres og forhindre yderligere downstream signalerer ved at defosforylere ZAP70/PI3K
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hvad binder KIRs?

A

HLA - A, B, C på target cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hvad binder KIRs?

A

HLA - A, B, C (MHC-I) på target cells.

Både aKIR og iKIR binder MHC-I, NK celler kan altså både blive aktiverede og inhiberede af MHC-I

17
Q

NKG2 familien består af? Og hvilke er aktiverende og inhiberende?

A

NKG2A: Inhiberende!
NKG2C: Aktiverende.
NKG2D: Stærkt aktiverende.

18
Q

Hvor udtrykkes MICA og hvad binder de til?

A

gastric and glandular epithelial cells
in the form of intracellular MICA ( 44 ). These proteins
are induced only by stress in virally infected cells and
tumors, with MICA widely reported in cancers of the
lung, breast, kidney, prostate, ovary, colon, melanoma,
and leukemia

  • MICA/B er ligander for NKG2D receptoren.
19
Q

Hvad er DNAM-1?

A
  • DNAX accessory molecule 1 (DNAM-1)
  • Kontinuerligt udtrykt aktiverende receptor på NK Celler og CTLs bruges til hårdføre tumor celler der er resistente til NK Celle medieret cytotoxicitet.
20
Q

Hvordan kan en tumor undgår drab af NK celler?

A
  • Tumorer kan lave opløseligt MICA/B som snyder NKG2D receptoren på NK celler.
  • Tumoren kan udskille TGF-beta som kan nedregulere NKG2D receptor og NCR receptor.
21
Q

How can you take advantage of receptor/ligand interactions to increase NK Cell Tumor control/recognition?

A

1) Antibody- Dependent Cell- Mediated
Cytotoxicity - Øge recognition af tumorer via mAbs
2) Checkpoint Blockade Therapy - In NK cells, an exhausted phenotype is indicated by higher expression of inhibitory receptors including KIR3DL1 , KIR2DL3 , and PD- 1 , and a lower expression of activating receptors such as NKG2D and NKp46. - Frigør inhiberende checkpoints så som PD-1, NKG2A eller iKIRs ved at binde et antistof til liganden så receptoren ikke aktiveres.
3) Allogeneic NK cell therapy - NK cells mismatched for iKIR-MHC I with the recipient, have iKIRs that do not recognize donor MHC I and thus are not inhibited, freeing them to recognize stress ligands on transformed tumor cells.
4) Antibody - BiKE and TRiKE - dual and triple antibody linking of tumor to NK Cells to enhance ADCC.

22
Q

Hvad er CAR? Og CAR NK Cells?

A
  • Chimeric antigen receptor (CAR) - giver mulighed for at genkende et specifict antigen.
  • Øger NK cellernes tumor specificitet og genkendelse.
23
Q

NK Cells have two major functions - which are?

A

1) Cytoxicity (CD56+, CD16++)

2) Cytokine production, IFN-g (CD56++, CD16low)

24
Q

Where can you find NK Cells?

A

They travel around in the body like (activated) T cells. That is, in blood, lymph and in tissue. The whole body more or less.

25
Q

Hvad afgør om en NK Celle aktiveres?

A
  • Balancen mellem aktiverende og inhiberende signaler.
  • Især missing self/lack of MHC-I er aktiverende.
  • Kræver ofte mindst 2 aktiverende receptorer (NKG2D eller IgG) og resulterer i cytotoxicitet, cytokiner eller begge.
26
Q

Hvis en celle er bundet af et antistof, skal NK Cellen så bruge andre aktiverende signaler?

A
  • Nej, har en celle Antistoffer bundet til sig, er det nok til at aktivere en NK celle igennem dens CD16 (Fc receptor)
27
Q

Hvilke NK Celle receptorer binder MHC I, og hvilken effekt har det?

A
  • NKG2A eller iKIR
    1) NKG2A binder MHC-I (HLA-E) og giver et inhiberende signal.
    2) KIRs binder til specifikke HLA-A,-B, -C og-G alleler og er ofte inhiberende. De kan dog også være aktiverende.
28
Q

NK Celle uddannelse sker på hvilken måde?

A
  • En balance mellem aktiverende og inhiberende signaler -> Licensing.
  • Sker i bone marrow.
  • Mere negativ signal i licensing = flere positive signaler i balanceringen og nemmere aktivering i vævet.

1) Umoden NK Celle udtrykker iKIR som genkender self-HLA-C, dette aktiverer SHP-1 phosphotase som forhindrer NK Celle aktivering ved at de-p Vav1.
2) Signaler fra aktiverende receptorer (eks. 2B4 eller NKG2D) fosforylerer Vav1.
3) En dynamisk balance mellem de-p-Vav1 og p-Vav1 uddanner cellen.
4) Cellen går til periferien hvor balancen er opretholdt indtil den møder inhiberende ligander (fra sunde celler) eller aktiverende ligander fra en syg celle som aktiverer den ved at danne flere p-Vav-1 end de-p-Vav1

  • Because of the variation in HLA-A,-B and -C motifs, we have differences all of us. Meaning some will have more inhibitory signals than others, and others will have less inhibitory signals –> Donor muligheder. Kunne angribe raskt væv, det ser vi dog ikke, vi ved ikke hvorfor.
  • You are only licensed if you get a negative signal (could be MHC-I or another). The more negative signals they get, the more positive signals they will get in the balance, and the easier it till be to activate them when needed.
  • You can also have unlicensed NK Cells, if you don’t have a build up of negative and positive signals in a balance. They will just have to have more positive signals.
29
Q

Har NK Celler både NKG2A og iKIRs?

A
  • Umodne NK Celler udtrykker først NKG2A:CD94 og derefter iKIRs.
  • Er der ingen KIRs der binder MHC-1, så opretholder cellen ekspression af CD94:NKG2A som sin eneste inhiberende receptor for MHC-I (kan være godt i tumorer da disse vil være mere aktive!).
  • Er der iKIRs der binder MHC-I, nedregulerer cellen ofte, men ikke altid, NKG2A.
30
Q

Udtrykker NK Celler kun en type receptorer?

A
  • Nej, NK celler udtrykker en diverse kombination af receptorer som er forskellige, men ikke nødvendighvis unikke (ingen somatisk hypermutation eller hypervariabilitet).
31
Q

NKG2D er hvilken type NK Cell receptor, og hvilke ligander binder den? Og hvornår ses disse ligander?

A
  • En aktiverende NK Celle receptor som binder ligander induceret af:
    1) Celle stress
    2) Infektion
    3) Transformation
32
Q

Hvad kan være en NKG2D shortcoming?

A

1) Tumorer/cancer kan producere opløselig MICA/NKG2D ligand som aktiverer NK og CD8+ T celler. Undgår selv at blive dræbt.
2) Kronisk inflammation kan udtrykke NKG2D ligander på overfladen og udarte sig i kronisk inflammation eller autoimmunitet
3) Vira eller bakterier kan indsætte NKG2D ligander på indersiden af membranen istedet for ydersiden.

33
Q

Har NK Celler hukommelse?

A
  • Ikke på samme måde som det adaptive immun system. MEN.
  • Ved CMV infektioner ses det at aktiverede effektor NK cellerne ændrer phenotype. (Får bl.a. flere NKG2C, en aktiverende receptor.) –> kaldes Trained Immunity
34
Q

Hvad er trained immunity?

A
  • Det at efter en infektion, får innate immunceller, NK Celler, en epigenetisk reprogrammering der ændrer deres phenotype til at have flere effector funktioner.
35
Q

Hvad præsenterer HLA-E? Og hvad binder CD94:NKG2A?

A
  • Leader-peptide sequences fra HLA-A,-B og -C

(Den første del af HLA-A,-b og -C som derefter kommes i HLA-E “kløften”)

  • CD94:NKG2A binder HLA-E (MHC-I)
36
Q

Hvad er de to overordnede strategier for NK Cell immunoterapi?

A
  • Prepare NK Cells ex vivo and transplant them - for example with CAR NK cells
  • Change/act in the microenviroment around a tumor in vivo.

Both could rely on blocking of inhibitory receptors or activating activatory receptors.

37
Q

Nævn 3 strategier for aktivering af NK Celler i cancer

A

1) Addition of activating cytokines, yet they have seen to be ineffective.
2) Histone demethylation or deacetylating agents (activation) of proinflammatory genes
3) Administration of mAbs triggering activation or inhibiting checkpoints or binding the tumor to the NK Cells via BiKE’s or TRiKE’s. CD16 (Fc receptor) can induce Antibody-dependent cell-mediated cytotoxicity (ADCC) alone.

38
Q

How is it with number of NK Cells and the tumour microenvironment?

A
  • NK Cell infiltration has been detected in multiple solid tumors and - High NK Cell infiltration = high survivability. But they normally comprise of only minor populations. AND it might now have been the proper markers for NK Cells, as other cells express these as well.
  • It seems however that the NK Cells mostly reside outside the tumor nest (TN) and are more present in the perifery (parenchym) and therefore lack the direct contact needed for ADCC.
39
Q

How does the tumour microenvironment affect NK Cell function?

A
  • It seems to inhibit the ADCC NK Cell phenotype via Tregs, supresive cytokines produced by other immune cells and by inhibitory mechanisms from the tumour itself.